novo nordisk semaglutide clinical trials announced headline results from STEP UP, a phase IIIb trial investigating subcutaneous 7.2 mg for obesity Novo Nordisk's semaglutide aces another

Nebulised salbutamol can be used in the treatment of hyperkalaemia [unlicensed in the UK]

Because Wegovy directly affects the gastrointestinal system by slowing down the rate at which your stomach empties, the majority of the side effects experienced during the first week are related to digestion

A3: While often marketed for various skin types, individuals with sensitive skin should perform a patch test

Jacoby, D

Physician-assisted weight loss is an effective solution for people who struggle to lose weight but are at risk of obesity-related conditions

Medication selection should consider the patient's comorbidity profile, previous medication responses, potential drug interactions, and individual preferences